- Fujirebio Diagnostics, Inc., a subsidiary of H.U. Group, has acquired Plasma Services Group, Inc., a US-based supplier of rare biological materials.
- The acquisition strengthens Fujirebio’s position in the IVD market and enhances its role as a CDMO partner.
Fujirebio Diagnostics, Inc., part of H.U. Group Holdings Inc., has completed the acquisition of all shares in Plasma Services Group, Inc., a company specialising in rare biological sample collection and supply for the in vitro diagnostics (IVD) and life science sectors. The transaction value has not been disclosed.
The acquired company, founded in 2004, operates out of a certified facility in Moorestown, New Jersey, and is recognised for its ability to source and distribute rare disease samples and biological materials. Its services include global sample collection and the supply of materials used in control reagents and calibrators.
Goki Ishikawa, President and CEO of Fujirebio Holdings, welcomed the deal, stating: “We are excited to welcome Plasma Services Group, a company that has gained a solid reputation as a reliable global supplier of difficult-to-obtain biological raw materials to the life sciences industry, to the Fujirebio group of companies.”
Nichelle Fernandez, President of Plasma Services Group, added that the acquisition allows the company to continue delivering quality and responsive service, while expanding its global impact within the IVD landscape.
The acquisition is expected to enhance Fujirebio’s offering as a trusted CDMO partner, particularly in areas requiring access to specialised and rare biological materials for diagnostics development and manufacturing.
Stay ahead of trends and best practices
